Published in Pharma Law Weekly, July 18th, 2006
The Rating Outlook has been revised to Stable from Negative. The ratings apply to approximately $3.27 billion of debt securities.
Schering-Plough has been able to resolve a range of significant operational and legal challenges over the past few years, resulting in a credit profile that has stabilized as demonstrated by sustained strong growth of revenues, expansion of margins, and reduction of leverage....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly